We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+18.68%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.69B
AUM Growth
+$682M
Cap. Flow
-$395M
Cap. Flow %
-5.9%
Top 10 Hldgs %
54.02%
Holding
678
New
246
Increased
85
Reduced
72
Closed
235

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$85.8M
2
INDV icon
Indivior Pharmaceuticals
INDV
+$59.6M
3
BCAX
Bicara Therapeutics
BCAX
+$45.8M
4
MRUS
Merus
MRUS
+$34.4M
5
VTRS icon
Viatris
VTRS
+$30M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$102M
2
SGRY icon
Surgery Partners
SGRY
+$86.4M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$53.7M
4
IART icon
Integra LifeSciences
IART
+$42.8M
5
BNTX icon
BioNTech
BNTX
+$38.6M

Sector Composition

Rank Sector Weight
1 Healthcare 87.45%
2 Industrials 0.73%
3 Technology 0.55%
4 Financials 0.45%
5 Consumer Discretionary 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UHS icon
326
Universal Health Services
UHS
$10.2B
$396K 0.01%
1,730
+611
+55% +$132K
SONO icon
327
Sonos
SONO
$2.09B
$395K 0.01%
+32,156
New +$408K
PRDO icon
328
Perdoceo Education
PRDO
$2.17B
$395K 0.01%
17,759
-34,529
-66% -$777K
ACN icon
329
Accenture
ACN
$106B
$393K 0.01%
+1,111
New +$365K
CGBD icon
330
Carlyle Secured Lending
CGBD
$708M
$390K 0.01%
+23,006
New +$397K
GTLS
331
DELISTED
Chart Industries
GTLS
$389K 0.01%
3,130
-2,277
-42% -$299K
OHI icon
332
Omega Healthcare
OHI
$15.3B
$387K 0.01%
9,509
-7,645
-45% -$289K
FNF icon
333
Fidelity National Financial
FNF
$14.4B
$386K 0.01%
+6,223
New +$349K
SBR
334
Sabine Royalty Trust
SBR
$1.06B
$385K 0.01%
+6,234
New +$391K
EAT icon
335
Brinker International
EAT
$8.82B
$382K 0.01%
+4,987
New +$343K
MSFT icon
336
Microsoft
MSFT
$2.9T
$381K 0.01%
+885
New +$378K
AMN icon
337
AMN Healthcare
AMN
$1.35B
$377K 0.01%
+8,893
New +$466K
SFBS
338
ServisFirst Bancshares
SFBS
$4.9B
$376K 0.01%
+4,669
New +$355K
CALM icon
339
Cal-Maine
CALM
$4.43B
$372K 0.01%
+4,968
New +$344K
LTC
340
LTC Properties
LTC
$2.13B
$367K 0.01%
10,014
-7,425
-43% -$269K
CODI icon
341
Compass Diversified
CODI
$752M
$366K 0.01%
+16,537
New +$361K
NXPI icon
342
NXP Semiconductors
NXPI
$60.8B
$359K 0.01%
+1,496
New +$375K
IRMD icon
343
iRadimed
IRMD
$1.2B
$359K 0.01%
+7,137
New +$329K
XRX icon
344
Xerox
XRX
$345M
$357K 0.01%
+34,420
New +$368K
INGR icon
345
Ingredion
INGR
$6.42B
$357K 0.01%
+2,598
New +$330K
KSS icon
346
Kohl's
KSS
$2.16B
$356K 0.01%
16,877
-13,289
-44% -$271K
RMBS icon
347
Rambus
RMBS
$8.95B
$347K 0.01%
+8,230
New +$399K
MUR icon
348
Murphy Oil
MUR
$5.55B
$346K 0.01%
10,243
-12,212
-54% -$461K
SNV
349
DELISTED
Synovus
SNV
$343K 0.01%
+7,703
New +$337K
TNC icon
350
Tennant Co
TNC
$1.44B
$342K 0.01%
+3,564
New +$348K
12 13
14
15 16

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2024 Portfolio in Review

As of Q3 2024, Deerfield Management held 678 positions worth $6.69B, up 11% from $6.01B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $395M in Q3 2024, closing 235 positions and reducing 72 holdings. Its most notable exit was Gilead Sciences, an estimated $102M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 83% a quarter earlier, followed by Industrials and Technology.

Against the trend, Deerfield Management opened a new position in Indivior Pharmaceuticals worth $49.7M.

  • Deerfield Management's largest Q3 2024 buy was Indivior Pharmaceuticals: 5,092,642 shares worth $49.7M.
  • Deerfield Management added most to Neurocrine Biosciences in Q3 2024, an estimated $85.8M increase.
  • Deerfield Management's biggest Q3 2024 reduction was Surgery Partners, cutting an estimated $86.4M.
  • Deerfield Management fully exited Gilead Sciences in Q3 2024, selling an estimated $102M.
  • Deerfield Management's ten largest holdings make up 54% of its $6.69B portfolio in Q3 2024.
  • Deerfield Management opened 246 new positions and closed 235 in Q3 2024.
  • Deerfield Management's portfolio value rose 11% quarter-over-quarter to $6.69B.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.